Combining the clinicopathological and survival information of these 54 patients, our analysis results showed that the expression of APCDD1L-AS1 was lower in ccRCC with higher tumor stage and histological grade (Fig. 1D) and patients in APCDD1L-AS1 low expression group had a shorter RFS (Relapse-free survival) (Fig. 1E). This evidence concerns the gene APCDD1L and neoplasm.